interaction between her-2 and hormone receptors in breast cancer

Authors

majid moghadaszadeh tabriz islamic azad university, tabriz, iran

alireza nikanfar hematology and oncology department, tabriz university of medical sciences, tabriz, iran

mohamadreza hemati tabriz islamic azad university, tabriz, iran

behrouz gharib hematology- oncology and stem cell research center, shariati hospital, tehran university of medical sciences, tehran, iran

abstract

introduction: breast cancer is the most common malignancy with more than one million new cases diagnosed annually all around the world. its growth is mostly regulated by steroid hormones such as estrogen and peptide growth factors in interaction with epidermal growth factor 1 and 2. methods and materials: in this study, 237 patients who had consulted the oncology clinic of tabriz university of medical sciences with pathologic diagnosis of breast cancer (from 2003 to 2010) were involved. data was extracted from medical records. results: from the total of 237 patients, 50.6% were er + , 48.9% were pr + and 37.1% were her-2 + . the greatest percentage of her-2positivity (51.6%) was detected in the age group of patients over 60 and the least in the group aged 31 to 40 yrs. the greatest percentage of hr + (71%) patients were also over 60 and the least (50%) were less than 30. 35.5% of patients in pre- menstrual period were her-2 + . hr was positive in 64% of ln + patients; her- 2 and hrwere positive in 35.4% and 65.4% while in ln - patients they were positive in 39% and 61.9% of cases, respectively. conclusion: acquired data showed reverse relation between the expression of epidermal growth factor ii and hormone receptors in breast cancer. 40-55% of cases with epidermal growth factor  expression lacked hormone receptors. co-existence of hormone  receptors and her-2 expression in breast cancer are considered as important prognostic factors.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Effect of hormone receptors and Her-2 status on metastasis status in patients with breast cancer using logistic regression model

Introduction: Breast cancer is the most common type of cancer and the leading cause of cancer death among women. According to estimates in 2018, the most frequency of cancer in Iranian women was related to breast cancer with 13776 (12.5%) new cases. Metastasis is a complication of this disease that occurs in 1%-5% of patients. The aim of this study was to investigate the effect of hormone recep...

full text

Re: Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer.

Recent clinical data (1) suggest that c-erbB-2 overexpression/amplification might be associated with tamoxifen resistance in patients with estrogen receptor (ER)-positive tumors. This association is controversial, however, and the question of the efficacy of hormone therapy in these patients is still a matter of debate. In a recent issue of the Journal, Konecny et al. (2) provided some answers ...

full text

Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer.

BACKGROUND HER-2/neu, which encodes a receptor tyrosine kinase, is amplified and overexpressed in 20%-25% of human breast cancers. Such tumors are often resistant to hormone therapy. Despite a general inverse association between HER-2/neu amplification/overexpression and estrogen receptor (ER) and/or progesterone receptor (PR) expression, a fraction of patients are both HER-2/neu- and hormone r...

full text

Role of Cyclooxygenese-2 (COX-2) Expression in Breast Cancer Differentiation and Its Relationship with Hormone Receptors Status

Background and Objectives: Cyclooxygenese-2 (COX-2) expression in breast cancer and its correlation with tumor prognosis is unclear. We investigated the incidence of COX-2 expression in patients and assessed interactions between COX-2 and clinical features of cancer and expression of HER2/neu, estrogen receptor (ER), and progesterone receptor (PR). Methods: COX-2 expression was investigated by...

full text

Relation between Estrogen and Progesterone Receptor Status with p53, Ki67 and Her-2 Markers in Patients with Breast Cancer

Background: Breast cancer is the most common cancer in women, containing approximately one third of all illnesses in women. Assessment of molecular markers is valuable in predicting the outcome of disease and decision making for optimal treatment. The purpose of this study was to determine the relationship between estrogen and progesterone receptors with Her-2, Ki67, P53, and clinicopathologica...

full text

Correlation of ER, PR, HER- 2 and P53 Immunoreactions with Clinico-Pathological Features in Breast Cancer

  Background and Objectives: The most prevalent malignancy among women is known to be breast cancer (BC). Several factors contribute to determining tumor prognosis and treatment strategies. In this study, the frequency and relevance of these factors are discussed. Materials and Methods: This cross-sectional study was carried out on 214 patients with BC, who referred to the Cancer Institute of...

full text

My Resources

Save resource for easier access later


Journal title:
international journal of hematology-oncology and stem cell research

جلد ۴، شماره ۴، صفحات ۱۴-۱۶

Keywords
[ ' b r e a s t c a n c e r ' , ' h e r ' , 2 , ' h o r m o n e r e c e p t o r s ' ]

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023